BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 280252)

  • 1. Interaction of 5,6- and 5,7-dihydroxytryptamine with tissue monoamine oxidase.
    Klemm HP; Baumgarten HG
    Ann N Y Acad Sci; 1978 Jun; 305():36-56. PubMed ID: 280252
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro studies on the interaction of brain monoamine oxidase with 5,6- and 5,7-dihydroxytryptamine.
    Klemm HP; Baumgarten HG; Schlossberger HG
    J Neurochem; 1979 Jan; 32(1):111-9. PubMed ID: 759562
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
    Da Prada M; Pieri L; Keller HH; Pieri M; Bonetti EP
    Ann N Y Acad Sci; 1978 Jun; 305():595-620. PubMed ID: 152083
    [No Abstract]   [Full Text] [Related]  

  • 4. Model of central chemical 'serotoninectomy' in mice.
    Herman ZS; Bonczek A
    Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 5,6-dihydroxytryptamine on the release, synthesis, and storage of serotonin: studies using rat brain synaptosomes.
    Wolf WA; Bobik A
    J Neurochem; 1988 Feb; 50(2):534-42. PubMed ID: 2447243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroxytryptamines as tools to study the neurobiology of serotonin.
    Baumgarten HG; Klemm HP; Sievers J; Schlossberger HG
    Brain Res Bull; 1982; 9(1-6):131-50. PubMed ID: 7172024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor effects of serotonin in the central nervous system.
    Gerson SC; Baldessarini RJ
    Life Sci; 1980 Oct; 27(16):1435-51. PubMed ID: 6160367
    [No Abstract]   [Full Text] [Related]  

  • 8. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5.7-dihydroxytryptamine injection.
    Barbeau H; Bédard P
    Neuropharmacology; 1981 May; 20(5):477-81. PubMed ID: 6165921
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of drugs on the distribution of [14C]-5,6-dihydroxytryptamine and [14C]-5,7-dihydroxytryptamine in rat brain.
    Baumgarten HG; Klemm HP; Lachenmayer L; Schlossberger HG
    Ann N Y Acad Sci; 1978 Jun; 305():107-18. PubMed ID: 280244
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term effects of 5,7-dihydroxytryptamine administered at birth on the development of brain monoamines.
    Lytle LD; Jacoby JH; Nelson MF; Baumgarten HG
    Life Sci; 1974 Sep; 15(6):1203-17. PubMed ID: 4549961
    [No Abstract]   [Full Text] [Related]  

  • 11. The ability of local injection of 6-OHDA, 5,6-DHT and 5,7-DHT into the olfactory bulbs to mimic the effects of bilateral bulbectomy in the rat [proceedings].
    Cairncross KD; Cox B; Forster C; Wren A
    Br J Pharmacol; 1977 Sep; 61(1):145P-146P. PubMed ID: 912193
    [No Abstract]   [Full Text] [Related]  

  • 12. Degenerative effects of various neurotoxic indoleamines on central monoamine neurons.
    Nobin A; Björklund A
    Ann N Y Acad Sci; 1978 Jun; 305():305-27. PubMed ID: 360938
    [No Abstract]   [Full Text] [Related]  

  • 13. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
    Stewart RM; Campbell A; Sperk G; Baldessarini RJ
    Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
    [No Abstract]   [Full Text] [Related]  

  • 14. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
    Frankfurt M; Allen DL; Luine VN; Beaudet A
    Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine.
    Siegel RA; Weidenfeld J; Chen M; Feldman S; Melamed E; Chowers I
    Mol Cell Endocrinol; 1983 Aug; 31(2-3):253-9. PubMed ID: 6195032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
    Mueller RA; Towle A; Breese GR
    Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polarographic measurements of spontaneous and mitochondria-promoted oxidation of 5,6- and 5,7-dihydroxytryptamine.
    Klemm HP; Baumgarten HG; Schlossberger HG
    J Neurochem; 1980 Dec; 35(6):1400-8. PubMed ID: 7441258
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia.
    Chance WT; von Meyenfeldt M; Fischer JE
    Pharmacol Biochem Behav; 1983 Jan; 18(1):115-21. PubMed ID: 6187026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual behavior in male rats after intracerebral injection of 5,7-dihydroxytryptamine.
    Larsson K; Fuxe K; Everitt BJ; Holmgren M; Södersten P
    Brain Res; 1978 Feb; 141(2):293-303. PubMed ID: 626904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.